Amit Misra

5.1k total citations
76 papers, 1.9k citations indexed

About

Amit Misra is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Amit Misra has authored 76 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 26 papers in Epidemiology and 23 papers in Infectious Diseases. Recurrent topics in Amit Misra's work include Inhalation and Respiratory Drug Delivery (28 papers), Tuberculosis Research and Epidemiology (16 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). Amit Misra is often cited by papers focused on Inhalation and Respiratory Drug Delivery (28 papers), Tuberculosis Research and Epidemiology (16 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). Amit Misra collaborates with scholars based in India, United States and South Africa. Amit Misra's co-authors include Rolee Sharma, Awadh Bihari Yadav, Rahul Kumar Verma, Pavan Muttil, Kaushlendra Kumar, Jatinder Kaur, Nicola Maffulli, Rajesh Kapur, Anil Kumar Dwivedi and A. Gupta and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Controlled Release and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Amit Misra

74 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amit Misra India 25 816 624 580 393 275 76 1.9k
Sadhna Sharma India 30 561 0.7× 747 1.2× 368 0.6× 600 1.5× 708 2.6× 88 2.6k
Lucila Garcia‐Contreras United States 25 1.1k 1.4× 645 1.0× 376 0.6× 268 0.7× 288 1.0× 52 1.7k
Pavan Muttil United States 22 724 0.9× 405 0.6× 413 0.7× 315 0.8× 250 0.9× 45 1.4k
Ali Azghani United States 25 582 0.7× 198 0.3× 147 0.3× 123 0.3× 705 2.6× 45 1.7k
Ronan MacLoughlin Ireland 28 916 1.1× 175 0.3× 197 0.3× 174 0.4× 835 3.0× 126 2.5k
David Cipolla Australia 29 1.5k 1.8× 735 1.2× 239 0.4× 98 0.2× 534 1.9× 84 2.5k
Imran Saleem United Kingdom 28 563 0.7× 612 1.0× 173 0.3× 90 0.2× 424 1.5× 67 1.8k
Andrea Civra Italy 26 130 0.2× 213 0.3× 418 0.7× 403 1.0× 565 2.1× 60 1.9k
Mamta Singh India 27 508 0.6× 60 0.1× 393 0.7× 308 0.8× 613 2.2× 81 2.2k
José M. Lanao Spain 22 172 0.2× 533 0.9× 201 0.3× 157 0.4× 674 2.5× 81 2.6k

Countries citing papers authored by Amit Misra

Since Specialization
Citations

This map shows the geographic impact of Amit Misra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amit Misra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amit Misra more than expected).

Fields of papers citing papers by Amit Misra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amit Misra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amit Misra. The network helps show where Amit Misra may publish in the future.

Co-authorship network of co-authors of Amit Misra

This figure shows the co-authorship network connecting the top 25 collaborators of Amit Misra. A scholar is included among the top collaborators of Amit Misra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amit Misra. Amit Misra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Misra, Amit & Rahul Singh. (2025). Marker Assisted Selection for Crop Improvement : A Review. PLANT CELL BIOTECHNOLOGY AND MOLECULAR BIOLOGY. 26(1-2). 103–117.
2.
Garg, Tanu, Hasham S. Sofi, Kavita Singh, et al.. (2025). Preclinical model of Mycobacteroides abscessus lung disease by nose-only exposure of mice to bacterial powder aerosol. Tuberculosis. 151. 102606–102606. 1 indexed citations
4.
Jain, Vikas, et al.. (2024). Mycobacteriophages: therapeutic approach for mycobacterial infections. Drug Discovery Today. 29(7). 104049–104049. 2 indexed citations
5.
Das, Ritam, et al.. (2024). Insights into the genomic features and lifestyle of B1 subcluster mycobacteriophages. Journal of Basic Microbiology. 64(6). e2400027–e2400027.
6.
Sofi, Hasham S., Sonia Verma, Sanjay Singh, et al.. (2024). Macrophage-targeted versus free calcitriol as host-directed adjunct therapy against Mycobacterium tuberculosis infection in mice is bacteriostatic and mitigates tissue pathology. Tuberculosis. 148. 102536–102536. 3 indexed citations
7.
8.
Sofi, Hasham S., Sonia Verma, Amit Kumar Singh, et al.. (2020). Transient Transfection of the Respiratory Epithelium with Gamma Interferon for Host-Directed Therapy in Pulmonary Tuberculosis. Molecular Therapy — Nucleic Acids. 22. 1121–1128. 9 indexed citations
9.
Ranjan, Rajeev, et al.. (2016). Opportunities and Challenges for Host-Directed Therapies in Tuberculosis. Current Pharmaceutical Design. 22(17). 2599–2604. 25 indexed citations
10.
Verma, Rahul Kumar, Prashant Khare, Dadi A. Srinivasarao, et al.. (2016). Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin B. International Journal for Parasitology Drugs and Drug Resistance. 6(2). 125–132. 10 indexed citations
11.
Agrawal, Atul, Rajeev Ranjan, Sharat Chandra, et al.. (2016). Some proteins of M. tuberculosis that localise to the nucleus of THP-1-derived macrophages. Tuberculosis. 101. 75–78. 5 indexed citations
12.
Hickey, Anthony J., Amit Misra, & P. Bernard Fourie. (2013). Dry Powder Antibiotic Aerosol Product Development: Inhaled Therapy for Tuberculosis. Journal of Pharmaceutical Sciences. 102(11). 3900–3907. 47 indexed citations
13.
Maikhuri, Jagdamba P., et al.. (2011). Biodegradable Nanoparticles in the Murine Vagina: Trans-Cervical Retrograde Transport and Induction of Proinflammatory Cytokines. Journal of Biomedical Nanotechnology. 7(1). 45–46. 8 indexed citations
14.
Verma, Rahul Kumar, et al.. (2011). Nanoparticles Containing Nitric Oxide Donor with Antileishmanial Agent for Synergistic Effect Against Visceral Leishmaniasis. Journal of Biomedical Nanotechnology. 7(1). 213–215. 5 indexed citations
15.
Misra, Amit. (2010). The science and politics behind the 'New Delhi' superbug.. Economic and political weekly. 45(40). 21–24. 5 indexed citations
16.
Misra, Amit, Anthony J. Hickey, Carlo Riccardo Rossi, et al.. (2010). Inhaled drug therapy for treatment of tuberculosis. Tuberculosis. 91(1). 71–81. 133 indexed citations
17.
Hokey, David A. & Amit Misra. (2010). Aerosol vaccines for tuberculosis: A fine line between protection and pathology. Tuberculosis. 91(1). 82–85. 23 indexed citations
18.
Muttil, Pavan, Jatinder Kaur, Kaushlendra Kumar, et al.. (2007). Inhalable microparticles containing large payload of anti-tuberculosis drugs. European Journal of Pharmaceutical Sciences. 32(2). 140–150. 144 indexed citations
19.
Siddiqui, Anees A., Amit Arora, Nasir A. Siddiqui, & Amit Misra. (2005). Synthesis of some 1,2,4-triazoles as potential antifungal agents. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 44(4). 838–841. 11 indexed citations
20.
Sharma, Rolee, et al.. (2001). Inhalable Microparticles Containing Drug Combinations to Target Alveolar Macrophages for Treatment of Pulmonary Tuberculosis. Pharmaceutical Research. 18(10). 1405–1410. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026